LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets14Federal Circuit179Pharma & ANDA40PTAB150Supreme Court9USPTO Policy27Patent Litigation55Patent Prosecution20ITC / Section 33732Trademark43Unsorted35

Tagged secondary considerations · clear

Federal Circuit

Free Samples and Fillers: No Teaching Away or Commercial Success

Written by : Kenneth McNeill & Daniel P. Hughes INCEPT LLC v. PALETTE LIFE SCIENCES, INC. Before Newman, Schall , and Taranto. Appeal from the Patent Trial and Appeal Board. Summary : No teaching away when art does not disparage invention and free samples…

August 24, 2023·Federal Circuit·1 min read
PTAB

Evidence of Commercial Success and the Prior Art

Written by : Nima Zargari, Ph.D. & Nathan D. Reeves YITA LLC V. MACNEIL IP LLC Before Taranto , Chen, and Stoll. Appeal from the Patent Trial and Appeal Board. Summary : Evidence of commercial success that relates entirely to an individual claim element…

June 8, 2023·PTAB·1 min read
Federal Circuit

Objective Evidence in Determining Obviousness

MEDTRONIC, INC. v. TELEFLEX INNOVATIONS Before Moore , Lourie, and Dyk. Appeal from the Patent Trial and Appeal Board. Summary : A close prima facie case of obviousness can be overcome by strong evidence of objective indicia of non-obviousness. Medtronic…

June 7, 2023·Federal Circuit·1 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data